Self/nonselfPub Date : 2010-10-01DOI: 10.4161/self.1.4.13946
Noah A Capurso, Michael Look, Laura Jeanbart, Heba Nowyhed, Clara Abraham, Joe Craft, Tarek M Fahmy
{"title":"Development of a nanoparticulate formulation of retinoic acid that suppresses Th17 cells and upregulates regulatory T cells.","authors":"Noah A Capurso, Michael Look, Laura Jeanbart, Heba Nowyhed, Clara Abraham, Joe Craft, Tarek M Fahmy","doi":"10.4161/self.1.4.13946","DOIUrl":"https://doi.org/10.4161/self.1.4.13946","url":null,"abstract":"<p><p>Retinoic acid (RA) is a small molecule capable of shunting developing T cells away from the Th17 lineage and towards the Treg phenotype, making it a potentially useful therapeutic for autoimmune and inflammatory diseases. However, therapy can be complicated by systemic toxicity and unpredictable bioavailability, making a targeted drug delivery vehicle for local therapy desirable. A promising approach is the use of nanoparticles, which have been demonstrated to increase potency and decrease toxicity of therapies in a variety of disease models including Th17 mediated diseases. Nanoparticles can also be targeted to specific cell types via surface modification, further increasing the potential specificity of this approach. We therefore constructed a nanoparticulate drug delivery platform from poly(lactic-co-glycolic acid) (PLGA) capable of encapsulating and releasing RA. Here we report the fabrication, characterization, and in vitro bioactivity of this platform. We demonstrate that RA containing PLGA nanoparticles suppress IL-17 production and ROR-γ(t) expression in T cells polarized towards the Th17 phenotype in vitro with similar potency to that of free drug. Furthermore, we show that these particles enhance TGF-β dependent Foxp3 expression and IL-10 production of T cells in vitro with similar potency to free RA. Finally, we demonstrate that T cells polarized towards the Th17 phenotype in the presence of free and nanoparticulate RA have similarly suppressed ability to induce IL-6 production by fibroblasts. Our findings demonstrate the feasibility of RA delivery via biodegradable nanoparticles and represent an exciting technology for the treatment of autoimmune and inflammatory diseases.</p>","PeriodicalId":89270,"journal":{"name":"Self/nonself","volume":"1 4","pages":"335-340"},"PeriodicalIF":0.0,"publicationDate":"2010-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4161/self.1.4.13946","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29698785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Self/nonselfPub Date : 2010-10-01DOI: 10.4161/self.1.4.13904
Matthew P Baker, Helen M Reynolds, Brooke Lumicisi, Christine J Bryson
{"title":"Immunogenicity of protein therapeutics: The key causes, consequences and challenges.","authors":"Matthew P Baker, Helen M Reynolds, Brooke Lumicisi, Christine J Bryson","doi":"10.4161/self.1.4.13904","DOIUrl":"https://doi.org/10.4161/self.1.4.13904","url":null,"abstract":"<p><p>The immunogenicity of protein therapeutics has so far proven to be difficult to predict in patients, with many biologics inducing undesirable immune responses directed towards the therapeutic resulting in reduced efficacy, anaphylaxis and occasionally life threatening autoimmunity. The most common effect of administrating an immunogenic protein therapeutic is the development of a high affinity anti-therapeutic antibody response. Furthermore, it is clear from clinical studies that protein therapeutics derived from endogenous human proteins are capable of stimulating undesirable immune responses in patients, and as a consequence, the prediction and reduction of immunogenicity has been the focus of intense research. This review will outline the principle causes of the immunogenicity in protein therapeutics, and describe the development of pre-clinical models that can be used to aid in the prediction of the immunogenic potential of novel protein therapeutics prior to administration in man.</p>","PeriodicalId":89270,"journal":{"name":"Self/nonself","volume":"1 4","pages":"314-322"},"PeriodicalIF":0.0,"publicationDate":"2010-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4161/self.1.4.13904","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29698783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Self/nonselfPub Date : 2010-10-01DOI: 10.4161/self.1.4.13279
Alexander B Sigalov
{"title":"The SCHOOL of nature: IV. Learning from viruses.","authors":"Alexander B Sigalov","doi":"10.4161/self.1.4.13279","DOIUrl":"10.4161/self.1.4.13279","url":null,"abstract":"<p><p>During the co-evolution of viruses and their hosts, the latter have equipped themselves with an elaborate immune system to defend themselves from the invading viruses. In order to establish a successful infection, replicate and persist in the host, viruses have evolved numerous strategies to counter and evade host antiviral immune responses as well as exploit them for productive viral replication. These strategies include those that modulate signaling mediated by cell surface receptors. Despite tremendous advancement in recent years, the exact molecular mechanisms underlying these critical points in viral pathogenesis remain unknown. In this work, based on a novel platform of receptor signaling, the Signaling Chain HOmoOLigomerization (SCHOOL) platform, I suggest specific mechanisms used by different viruses such as human immunodeficiency virus (HIV), cytomegalovirus (CMV), severe acute respiratory syndrome coronavirus, human herpesvirus 6 and others, to modulate receptor signaling. I also use the example of HIV and CMV to illustrate how two unrelated enveloped viruses use a similar SCHOOL mechanism to modulate the host immune response mediated by two functionally different receptors: T cell antigen receptor and natural killer cell receptor, NKp30. This suggests that it is very likely that similar general mechanisms can be or are used by other viral and possibly non-viral pathogens. Learning from viruses how to target cell surface receptors not only helps us understand viral strategies to escape from the host immune surveillance, but also provides novel avenues in rational drug design and the development of new therapies for immune disorders.</p>","PeriodicalId":89270,"journal":{"name":"Self/nonself","volume":"1 4","pages":"282-298"},"PeriodicalIF":0.0,"publicationDate":"2010-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062383/pdf/self0104_0282.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29810732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Self/nonselfPub Date : 2010-10-01DOI: 10.4161/self.1.4.13990
Anouk Regeling, Rajesh Somasundaram, Colin de Haar, C Janneke van der Woude, Henri Braat, Maikel P Peppelenbosch
{"title":"Role of defective autophagia and the intestinal flora in Crohn disease.","authors":"Anouk Regeling, Rajesh Somasundaram, Colin de Haar, C Janneke van der Woude, Henri Braat, Maikel P Peppelenbosch","doi":"10.4161/self.1.4.13990","DOIUrl":"https://doi.org/10.4161/self.1.4.13990","url":null,"abstract":"<p><p>The precise mechanisms underlying the development of Crohn disease (CD) remain controversial, but sufficient data have been collected to suggest that an uncontrolled immune response within the intestinal mucosa leads to inflammation in a genetically susceptible host. Although lack of mucosal regulatory T cells causes colitis in humans and experimental rodents, patients with CD have more rather than less regulatory activity in the intestine, apparently excluding defects in tolerance as the cause of CD. Genome-wide association studies have identified many gene variants that confer susceptibility and which seem associated to diminished functioning of especially innate immunity. In apparent agreement, CD patients are impaired with respect to innate immune responses and controlling bacterial flora in the intestine. Furthermore, severe genetic deficiencies in innate immunity, like e.g., lack of NADP oxidase activity or diminished function of the Wiskott Aldrich syndrome protein are associated with colitis in mice and men, and are often mistakenly diagnosed as CD. Thus we favor the view that the primary defect in CD is a lack in innate immunity, causing second tier immunological defenses to combat otherwise easily controlled bacterial breaches of the mucosal barrier.</p>","PeriodicalId":89270,"journal":{"name":"Self/nonself","volume":"1 4","pages":"323-327"},"PeriodicalIF":0.0,"publicationDate":"2010-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4161/self.1.4.13990","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29698786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"No human protein is exempt from bacterial motifs, not even one.","authors":"Brett Trost, Guglielmo Lucchese, Angela Stufano, Mik Bickis, Anthony Kusalik, Darja Kanduc","doi":"10.4161/self.1.4.13315","DOIUrl":"https://doi.org/10.4161/self.1.4.13315","url":null,"abstract":"<p><p>The hypothesis that mimicry between a self and a microbial peptide antigen is strictly related to autoimmune pathology remains a debated concept in autoimmunity research. Clear evidence for a causal link between molecular mimicry and autoimmunity is still lacking. In recent studies we have demonstrated that viruses and bacteria share amino acid sequences with the human proteome at such a high extent that the molecular mimicry hypothesis becomes questionable as a causal factor in autoimmunity. Expanding upon our analysis, here we detail the bacterial peptide overlapping to the human proteome at the penta-, hexa-, hepta- and octapeptide levels by exact peptide matching analysis and demonstrate that there does not exist a single human protein that does not harbor a bacterial pentapeptide or hexapeptide motif. This finding suggests that molecular mimicry between a self and a microbial peptide antigen cannot be assumed as a basis for autoimmune pathologies. Moreover, the data are discussed in relation to the microbial immune escape phenomenon and the possible vaccine-related autoimmune effects.</p>","PeriodicalId":89270,"journal":{"name":"Self/nonself","volume":"1 4","pages":"328-334"},"PeriodicalIF":0.0,"publicationDate":"2010-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4161/self.1.4.13315","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29698784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Self/nonselfPub Date : 2010-10-01DOI: 10.4161/self.1.4.13560
Julien Matricon, Nicolas Barnich, Denis Ardid
{"title":"Immunopathogenesis of inflammatory bowel disease.","authors":"Julien Matricon, Nicolas Barnich, Denis Ardid","doi":"10.4161/self.1.4.13560","DOIUrl":"https://doi.org/10.4161/self.1.4.13560","url":null,"abstract":"<p><p>Inflammatory bowel disease (IBD) is a group of idiopathic, chronic and relapsing inflammatory conditions of the gastrointestinal tract. Familial and epidemiological studies have stressed the involvement of genetic factors and have also shown the critical role of environmental factors such as sanitation and hygiene in the development of IBD. However, the molecular mechanisms of intestinal inflammation in IBD have long remained unknown. In recent years, the study of susceptibility genes involved in the detection of bacterial components and in the regulation of the host immune response has shed light onto the potential role of intestinal pathogens and gut flora in IBD immunobiology. This review presents current knowledge on intestinal epithelial barrier alterations and on dysfunction of mucosal innate and acquired immune responses in IBD. The data support the etiological hypothesis which argues that pathogenic intestinal bacteria and/or infectious agents initiate and perpetuate the inflammation of the gut through disruption of tolerance towards the commensal microbiota in an individual with genetic vulnerability.</p>","PeriodicalId":89270,"journal":{"name":"Self/nonself","volume":"1 4","pages":"299-309"},"PeriodicalIF":0.0,"publicationDate":"2010-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4161/self.1.4.13560","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29810731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Self/nonselfPub Date : 2010-07-01Epub Date: 2010-07-02DOI: 10.4161/self.1.3.12891
Marc Derive, Frédéric Massin, Sébastien Gibot
{"title":"Triggering receptor expressed on myeloid cells-1 as a new therapeutic target during inflammatory diseases.","authors":"Marc Derive, Frédéric Massin, Sébastien Gibot","doi":"10.4161/self.1.3.12891","DOIUrl":"https://doi.org/10.4161/self.1.3.12891","url":null,"abstract":"<p><p>The Triggering Receptor Expressed on Myeloid cells (TREM)-1 is a recently identified molecule involved in monocytic activation and inflammatory response. It belongs to a family related to Natural Killer cell-receptors and is expressed on neutrophils, mature monocytes and macrophages. The engagement of TREM-1 synergizes with several Toll Like Receptors (TLR) and/or NOD Like Receptors (NLR) activation in amplifying the inflammatory response mediated by microbial components or danger signals. The implication of TREM-1 during experimental models of acute or chronic inflammatory conditions, as well as during cancer, begins to understand. Furthermore, the modulation of the TREM-1 signaling pathway by the use of small synthetic peptides derived from its extracellular moiety confers interesting survival advantages during experimental murine septic shock and protects from organ damage during other inflammatory diseases. This review summarizes the recent advances on TREM-1 biology and highlights the promises of its therapeutic modulation.</p>","PeriodicalId":89270,"journal":{"name":"Self/nonself","volume":"1 3","pages":"225-230"},"PeriodicalIF":0.0,"publicationDate":"2010-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4161/self.1.3.12891","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29810370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Self/nonselfPub Date : 2010-07-01Epub Date: 2010-01-29DOI: 10.4161/self.1.3.11897
Darja Kanduc
{"title":"The self/nonself issue: A confrontation between proteomes.","authors":"Darja Kanduc","doi":"10.4161/self.1.3.11897","DOIUrl":"https://doi.org/10.4161/self.1.3.11897","url":null,"abstract":"<p><p>Defining self and nonself is the most compelling challenge in science today, at the basis of the numerous questions that remain unanswered in the immunology-pathology-therapy debate. The generation of the antibody repertoire, the complicated scenario offered by tolerance and autoimmunity, natural auto-antibodies and their relationship to autoimmune diseases, and positive and negative selection are only a few examples of the unresolved immunological questions. In this context, we proposed that sequence similarity to the host proteome modulates antigen peptide recognition and immunogenicity. Using the available proteome assemblies of viruses, bacteria and higher vertebrates, and applying the low-similarity criterion, we are systematically defining the proteomic similarity of B-cell epitopes already validated experimentally. Here, we report further data documenting that a low similarity to the host proteome is the common property that defines the immunological \"nonself\" nature of antigenic sequences in cancer, autoimmunity, infectious diseases and allergy.</p>","PeriodicalId":89270,"journal":{"name":"Self/nonself","volume":"1 3","pages":"255-258"},"PeriodicalIF":0.0,"publicationDate":"2010-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4161/self.1.3.11897","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29810374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Self/nonselfPub Date : 2010-07-01Epub Date: 2010-06-09DOI: 10.4161/self.1.3.12643
Mary S Wong, Wayne J Hawthorne, Nicholas Manolios
{"title":"Gene therapy in diabetes.","authors":"Mary S Wong, Wayne J Hawthorne, Nicholas Manolios","doi":"10.4161/self.1.3.12643","DOIUrl":"https://doi.org/10.4161/self.1.3.12643","url":null,"abstract":"<p><p>Type 1 diabetes (T1D) is a chronic autoimmune disease, whereby auto-reactive cytotoxic T cells target and destroy insulin-secreting β-cells in pancreatic islets leading to insulin deficiency and subsequent hyperglycemia. These individuals require multiple daily insulin injections every day of their life without which they will develop life-threatening diabetic ketoacidosis (DKA) and die. Gene therapy by viral vector and non-viral transduction may be useful techniques to treat T1D as it can be applied from many different angles; such as the suppression of autoreactive T cells to prevent islet destruction (prophylactic) or the replacement of the insulin gene (post-disease). The need for a better method for providing euglycemia arose from insufficient numbers of cadaver islets for transplantation and the immunosuppression required post-transplant. Ectopic expression of insulin or islet modification have been examined, but not perfected. This review examines the various gene transfer methods, gene therapy techniques used to date and promising novel techniques for the maintenance of euglycemia in the treatment of T1D.</p>","PeriodicalId":89270,"journal":{"name":"Self/nonself","volume":"1 3","pages":"165-175"},"PeriodicalIF":0.0,"publicationDate":"2010-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4161/self.1.3.12643","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29811516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Self/nonselfPub Date : 2010-07-01Epub Date: 2010-06-25DOI: 10.4161/self.1.3.12819
Vivian Wy Wong, Amy E Saunders, Amanda Hutchings, John C Pascall, Christine Carter, Nicholas A Bright, Simon A Walker, Nicholas T Ktistakis, Geoffrey W Butcher
{"title":"The autoimmunity-related GIMAP5 GTPase is a lysosome-associated protein.","authors":"Vivian Wy Wong, Amy E Saunders, Amanda Hutchings, John C Pascall, Christine Carter, Nicholas A Bright, Simon A Walker, Nicholas T Ktistakis, Geoffrey W Butcher","doi":"10.4161/self.1.3.12819","DOIUrl":"https://doi.org/10.4161/self.1.3.12819","url":null,"abstract":"<p><p>A mutation in the rat GIMAP5 gene predisposes for autoimmunity, most famously in the BB rat model of autoimmune type 1 diabetes mellitus. This mutation is associated with severe peripheral T lymphopenia, as is mutation of the same gene in mice, but the mechanism by which GIMAP5 normally protects T cells from death is unknown. GIMAP5 is a putative small GTPase, a class of proteins which often fulfil their functions in the vicinity of cellular membranes. The objective of this study was to determine the normal intracellular location of GIMAP5 in lymphoid cells. Combining studies in rat, mouse and human systems, novel monoclonal antibodies (mAbs) were used to examine the localization of GIMAP5 and the closely-related protein, GIMAP1, in lymphoid cells by means of confocal microscopy and sub-cellular fractionation combined with immunoblotting. Additionally, human Jurkat T cells that inducibly express epitope-tagged GIMAP5 were established and used in electron microscopy (EM). Endogenous GIMAP5 was found to be located in a membraneous compartment/s which was also detected by established markers of lysosomes. GIMAP1, by contrast, was found to be located in the Golgi apparatus. EM studies of the inducible Jurkat T cells also found GIMAP5 in lysosomes and, in addition, in multivesicular bodies. This study establishes that the endogenous location of GIMAP5 is in lysosomes and related compartments and provides a clearer context for hypotheses about its mechanism of action.</p>","PeriodicalId":89270,"journal":{"name":"Self/nonself","volume":"1 3","pages":"259-268"},"PeriodicalIF":0.0,"publicationDate":"2010-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4161/self.1.3.12819","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29810376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}